Pear Therapeutics Investor Relations Material
Latest events
Q3 2022
Pear Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Pear Therapeutics Inc
Access all reports
Pear Therapeutics Inc. is a healthcare company specializing in the development and commercialization of digital therapeutics. These software-based treatments are designed to address a range of medical conditions by delivering clinically validated behavioral therapies through mobile and desktop applications. Pear’s products target areas such as substance use disorder, insomnia, and mental health, aiming to provide personalized, evidence-based care to patients. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
PEAR
Country
🇺🇸 United States